Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.
about
PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cellsHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsAn efficient vector system to modify cells geneticallyEnhanced genetic modification of adult growth factor mobilized peripheral blood hematopoietic stem and progenitor cells with rapamycin.Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.Vpx mediated degradation of SAMHD1 has only a very limited effect on lentiviral transduction rate in ex vivo cultured HSPCs.Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction.Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.High-throughput screening identifies compounds that enhance lentiviral transduction.Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes.Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses.Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin.Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production.
P2860
Q24297436-455E8F54-3233-4D9B-9307-654039DB09CDQ26859147-3FF90B79-51E5-47C1-9817-8B740EC4600BQ28477924-8FEF6EE5-1F2E-494E-AE0E-AEEA66F1FC66Q34273081-784E233B-5E5B-41C9-8735-7E00CAA9EE63Q35087824-A6B7FF54-5821-465E-8C0B-2B72E0DE2844Q36306178-37708B76-CDA1-4AB5-BA90-DA8E56F26CE6Q36616895-91679AF7-B070-4461-9968-053C6ADDA437Q36861470-3756F22D-F1EC-4B2D-BD32-23B717A1B0C4Q37340427-E7C28672-07E4-4174-BEE6-370FD9B56FBBQ38690842-773CEB7E-7442-4FB6-8296-E1D78472A666Q38955557-2FF54110-4A8B-4C4C-B0FB-589C2C108A90Q38972497-2FDA594A-3B74-4E86-9DF3-D199C2B5B203Q40694315-97DC1ADE-DF13-46DF-B2FD-DCAC45BC87EDQ41433371-58EF555C-483F-481D-BF98-0D8457A18AA8Q42289776-37C7B697-96F1-42D7-ADBE-DA54EF03CA8BQ45869813-53C348D9-D26C-4A64-94B9-B6403A1309BAQ45870461-65877B40-704A-4763-9CFE-0008F6E4E7CBQ45873930-8F221325-0B46-4AFA-A823-93B9038C7A62Q45874313-9419D1CC-44ED-4424-B189-A652BDE0BB71Q46614290-A38E11D8-6337-470D-AFBF-C8DB28C9C2CFQ48157628-BE637FD7-F49E-4B60-823C-6FC1C359F0CBQ55004092-0B09A94F-2EAD-4442-A1E1-6638667C1B50
P2860
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Towards a clinically relevant ...... poietic stem/progenitor cells.
@ast
Towards a clinically relevant ...... poietic stem/progenitor cells.
@en
type
label
Towards a clinically relevant ...... poietic stem/progenitor cells.
@ast
Towards a clinically relevant ...... poietic stem/progenitor cells.
@en
prefLabel
Towards a clinically relevant ...... poietic stem/progenitor cells.
@ast
Towards a clinically relevant ...... poietic stem/progenitor cells.
@en
P2093
P2860
P1433
P1476
Towards a clinically relevant ...... poietic stem/progenitor cells.
@en
P2093
Allison Arndt
Maureen Boyd
Michelle Millington
Sylvie Shen
P2860
P356
10.1371/JOURNAL.PONE.0006461
P407
P577
2009-07-30T00:00:00Z